Oculomotor Behaviors and Integrative Memory Functions in the Alzheimer's Clinical Syndrome

被引:8
|
作者
Fernandez, Gerardo [1 ,2 ,3 ]
Parra, Mario A. [4 ]
机构
[1] ViewMind Inc, New York, NY USA
[2] Axis Neurociencias, Bahia Blanca, Buenos Aires, Argentina
[3] UNS, Inst Invest Ingn Elect IIIE, CONICET, Bahia Blanca, Buenos Aires, Argentina
[4] Univ Strathclyde, Sch Psychol Sci & Hlth, Glasgow, Lanark, Scotland
关键词
Alzheimer's disease; eye-tracking; gaze duration; pupil behavior; short-term memory binding test; SHORT-TERM-MEMORY; VISUAL WORKING-MEMORY; BINDING DEFICITS; COGNITIVE IMPAIRMENT; PUPILLARY RESPONSES; NEURONAL-ACTIVITY; LOCUS-COERULEUS; FEATURES; LIGHT; MICROSTIMULATION;
D O I
10.3233/JAD-201189
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Biological information drawn from eye-tracking metrics is providing evidence regarding drivers of cognitive decline in Alzheimer's disease. In particular, pupil size has proved useful to investigate cognitive performance during online activities. Objective: To investigate the oculomotor correlates of impaired performance of patients with mild Alzheimer's Clinical Syndrome (ACS) on a recently developed memory paradigm, namely the Short-Term Memory Binding Test (STMBT). Methods: We assessed a sample of eighteen healthy controls (HC) and eighteen patients with a diagnosis of mild ACS with the STMBT while we recorded their oculomotor behaviors using pupillometry and eye-tracking. Results: As expected, a group (healthy controls versus ACS) by condition (Unbound Colours versus Bound Colours) interaction was found whereby behavioral group differences were paramount in the Bound Colours condition. Healthy controls' pupils dilated significantly more in the Bound Colours than in the Unbound Colours condition, a discrepancy not observed in ACS patients. Furthermore, ROC analysis revealed the abnormal pupil behaviors distinguished ACS patients from healthy controls with values of sensitivity and specify of 100%, thus outperforming both recognition scores and gaze duration. Conclusion: The biological correlates of Short-Term Memory Binding impairments appear to involve a network much wider than we have thought to date, which expands across cortical and subcortical structures. We discuss these findings focusing on their implications for our understanding of neurocognitive phenotypes in the preclinical stages of Alzheimer's disease and potential development of cognitive biomarkers that can support ongoing initiatives to prevent dementia.
引用
收藏
页码:1033 / 1044
页数:12
相关论文
共 50 条
  • [1] Memory markers in the continuum of the Alzheimer’s clinical syndrome
    Mario A. Parra
    Clara Calia
    Vivek Pattan
    Sergio Della Sala
    Alzheimer's Research & Therapy, 14
  • [2] Memory markers in the continuum of the Alzheimer's clinical syndrome
    Parra, Mario A.
    Calia, Clara
    Pattan, Vivek
    Della Sala, Sergio
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [3] Distinctive Oculomotor Behaviors in Alzheimer's Disease and Frontotemporal Dementia
    Lage, Carmen
    Lopez-Garcia, Sara
    Bejanin, Alexandre
    Kazimierczak, Martha
    Aracil-Bolanos, Ignacio
    Calvo-Cordoba, Alberto
    Pozueta, Ana
    Garcia-Martinez, Maria
    Fernandez-Rodriguez, Andrea
    Bravo-Gonzalez, Maria
    Jimenez-Bonilla, Julio
    Banzo, Ignacio
    Irure-Ventura, Juan
    Pegueroles, Jordi
    Illan-Gala, Ignacio
    Fortea, Juan
    Rodriguez-Rodriguez, Eloy
    Lleo-Bisa, Alberto
    Garcia-Cena, Cecilia E.
    Sanchez-Juan, Pascual
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 12
  • [4] The functions of autobiographical memory: An integrative approach
    Harris, Celia B.
    Rasmussen, Anne S.
    Berntsen, Dorthe
    MEMORY, 2014, 22 (05) : 559 - 581
  • [5] Effects of memantine on memory and language functions in Alzheimer's disease
    Emre, Murat
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 414 - 414
  • [6] Confabulation, executive functions, and source memory in Alzheimer's disease
    Dalla Barba, G
    Nedjam, Z
    Dubois, B
    COGNITIVE NEUROPSYCHOLOGY, 1999, 16 (3-5) : 385 - 398
  • [7] "Alzheimer's disease" is neither "Alzheimer's clinical syndrome" nor "dementia"
    Jagust, William
    Jack, Clifford R., Jr.
    Bennett, David A.
    Blennow, Kaj
    Haeberlein, Samantha Budd
    Holtzman, David M.
    Jessen, Frank
    Karlawish, Jason
    Liu, Enchi
    Luis Molinuevo, Jose
    Montine, Thomas
    Phelps, Creighton
    Rankin, Katherine P.
    Rowe, Christopher C.
    Scheltens, Philip
    Siemers, Eric
    Sperling, Reisa
    ALZHEIMERS & DEMENTIA, 2019, 15 (01) : 153 - 157
  • [8] Executive functions in clinical and preclinical Alzheimer's disease
    Allain, P.
    Etcharry-Bouyx, F.
    Verny, C.
    REVUE NEUROLOGIQUE, 2013, 169 (10) : 695 - 708
  • [9] INCOMPLETE LOCKED-IN SYNDROME WITH PRESERVED OCULOMOTOR FUNCTIONS
    BUSHART, W
    BAUER, G
    GERSTENBRAND, F
    ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1980, 50 (3-4): : P128 - P129
  • [10] Memory functions and regional cerebral blood flow in Alzheimer's disease
    Elgh, EJE
    Nyberg, L
    Näsman, B
    Åhlström, KR
    Sundström, T
    INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2000, 35 (3-4) : 238 - 238